CureVac Appoints Thaminda Ramanayake as New Chief Business Officer

Mr. Ramanayake brings more than fifteen years of experience in biopharma company development and deal-makingStrong track record of successful clinical collaborations, M&A, asset in-licensing and strategic financing initiatives across multiple …
Jetzt den vollständigen Artikel lesen